Cagrilintide + Semaglutide Blend
Price range: $41 through $410
Dual-mechanism weight loss blend: Amylin analogue + GLP-1 agonist for next-generation metabolic research
... people are viewing this right now
Cagrilintide + Semaglutide Blend Research Guide
Overview
Cagrilintide + Semaglutide Blend combines two advanced metabolic compounds for dual-pathway weight management research. This formulation mirrors the investigational CagriSema combination.
Blend Components
Cagrilintide (Amylin Analogue)
- Long-acting amylin receptor agonist
- Reduces appetite and food intake
- Slows gastric emptying
- Regulates postprandial glucose
- Complements GLP-1 mechanism
Semaglutide (GLP-1 Agonist)
- Potent GLP-1 receptor agonist
- Enhances glucose-dependent insulin secretion
- Suppresses appetite via CNS pathways
- Promotes sustained satiety
- Well-characterized metabolic effects
Synergy Mechanism
The combination of amylin and GLP-1 pathways provides complementary appetite suppression through different neurological mechanisms, potentially exceeding single-agent efficacy.
Quality Standards
- Purity: >98% verified by HPLC for each component
- Form: Lyophilized powder
- Storage: -20°C long-term
- Documentation: Full CoA with individual component verification
For research purposes only. Not for human consumption.
| Select Minimum 10 Vials | 10mg*1vials, 10mg*10vials |
|---|



Reviews
There are no reviews yet.